NATIONAL JEWISH HEALTH
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1899-01-01
- Employees
- -
- Market Cap
- -
Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study
- First Posted Date
- 2017-01-05
- Last Posted Date
- 2021-03-08
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 10
- Registration Number
- NCT03010436
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study
- First Posted Date
- 2016-10-28
- Last Posted Date
- 2017-09-14
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 10
- Registration Number
- NCT02947945
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
IV Colistin for Pulmonary Exacerbations: Improving Safety and Efficacy
- First Posted Date
- 2016-09-29
- Last Posted Date
- 2023-04-21
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 51
- Registration Number
- NCT02918409
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
The Role of Bacterial Toxins in Human Skin Disease
- Conditions
- First Posted Date
- 2016-09-22
- Last Posted Date
- 2021-10-19
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 100
- Registration Number
- NCT02910791
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
The Role of Tapering Pace and Selected Traits on Hypnotic Discontinuation
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-07-13
- Last Posted Date
- 2019-10-30
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 74
- Registration Number
- NCT02831894
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
The Breathe Well Program for Adults With Asthma
- First Posted Date
- 2016-05-04
- Last Posted Date
- 2023-11-09
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 14978
- Registration Number
- NCT02761837
- Locations
- 🇺🇸
Kaiser Permanente of Colorado, Denver, Colorado, United States
Effects of p38 Inhibitor AZD7624 in Corticosteroid Resistant Asthma
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-04-28
- Last Posted Date
- 2019-08-21
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 2
- Registration Number
- NCT02753764
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
Colorado Marijuana Users Health Cohort
- Conditions
- Interventions
- First Posted Date
- 2016-04-13
- Last Posted Date
- 2019-03-13
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 2000
- Registration Number
- NCT02735954
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
Pneumococcal Post-Vaccination Titers
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2016-04-01
- Last Posted Date
- 2017-09-14
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 140
- Registration Number
- NCT02726347
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency
- Conditions
- First Posted Date
- 2016-02-25
- Last Posted Date
- 2019-03-13
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 39
- Registration Number
- NCT02691611
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
© Copyright 2024. All Rights Reserved by MedPath